What is the recommended treatment for a typical adult patient with urethral discharge, potentially caused by gonorrhea or chlamydia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Urethral Discharge

For adults with urethral discharge, initiate treatment with azithromycin 1 g orally as a single dose OR doxycycline 100 mg orally twice daily for 7 days after confirming urethritis through objective documentation. 1, 2, 3

Diagnostic Confirmation Required Before Treatment

Before initiating therapy, urethritis must be objectively documented using at least one of the following criteria:

  • Mucopurulent or purulent discharge on examination 4
  • Gram stain of urethral secretions showing ≥5 white blood cells per oil immersion field (≥2 WBCs per oil immersion field in women) 4, 1
  • First-void urine microscopy demonstrating ≥10 white blood cells per high-power field 4
  • Positive leukocyte esterase test on first-void urine 4

Critical caveat: Symptoms alone without objective evidence of urethral inflammation are insufficient for diagnosis or treatment initiation. 1 The absence of pyuria does not exclude sexually transmitted urethritis, as urethral swabs and first-catch urine have low sensitivity (29-62%) for detecting polymorphonuclear leukocytes in chlamydial and mycoplasma infections. 5

First-Line Treatment Regimens

Recommended options (choose one):

  • Azithromycin 1 g orally as a single dose 4, 1, 3

    • Advantage: Directly observed therapy with improved compliance 4, 1
    • May be more effective for Mycoplasma genitalium infections 4
  • Doxycycline 100 mg orally twice daily for 7 days 4, 1, 2

    • First-line for patients positive for both Mycoplasma genitalium and Ureaplasma 6

Both regimens are highly effective for chlamydial urethritis and have equivalent efficacy. 4, 1

Alternative Regimens

If first-line agents cannot be used:

  • Erythromycin base 500 mg orally four times daily for 7 days 4, 6
  • Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days 4, 6
  • Levofloxacin 500 mg orally once daily for 7 days 4, 6
  • Ofloxacin 300 mg orally twice daily for 7 days 4, 6

When to Treat Empirically for Gonorrhea

If gonococcal infection is suspected or confirmed, add ceftriaxone:

  • Ceftriaxone 500 mg IM as a single dose (for patients <150 kg) PLUS azithromycin 1 g orally 5, 7
  • This dual therapy addresses both gonorrhea and likely chlamydial co-infection 8, 7

Empiric treatment for both gonorrhea and chlamydia is indicated for:

  • Patients at high risk who are unlikely to return for follow-up (e.g., adolescents with multiple partners) 4
  • Patients with severe urethritis or inability to follow up 5

Testing Strategy

All patients with confirmed or suspected urethritis should be tested for both N. gonorrhoeae and C. trachomatis before or at time of treatment. 4, 1

  • Perform nucleic acid amplification testing (NAAT) on first-void urine or urethral swab 5
  • Gram stain is the preferred rapid diagnostic test for documenting urethritis and identifying gonococcal infection (intracellular Gram-negative diplococci) 4, 5
  • If NAAT is positive for gonorrhea, obtain culture for antimicrobial susceptibility testing 5

For mild symptoms with reliable follow-up: Consider delaying treatment until NAAT results guide pathogen-directed therapy. 5

Partner Management

All sexual partners within the preceding 60 days must be evaluated and treated with the same regimen as the index patient. 4, 1, 6

  • Partners should be treated even if asymptomatic 1, 6
  • Sexual abstinence is required for 7 days after treatment initiation and until symptoms resolve and partners are adequately treated 4, 1, 6

Follow-Up and Persistent Symptoms

Patients should return for evaluation only if symptoms persist or recur after completing therapy. 4, 1

  • Routine post-treatment testing is not recommended in asymptomatic patients 1
  • Symptoms alone without objective signs of urethritis are not sufficient for re-treatment 4

For persistent or recurrent urethritis:

  1. Re-treat with the initial regimen if non-compliant or re-exposed to untreated partner 4, 6
  2. If compliance was adequate and partner was treated, perform testing for Trichomonas vaginalis using NAAT or culture 1
  3. Consider treatment with metronidazole 2 g orally as a single dose PLUS azithromycin 1 g orally (if azithromycin was not used initially) 1
  4. For persistent cases, consider Mycoplasma genitalium with possible macrolide resistance, which may require moxifloxacin 400 mg daily for 7-14 days 5

Special Populations

Pregnant patients:

  • Azithromycin 1 g orally as a single dose is the preferred treatment due to safety and effectiveness 1
  • Doxycycline and fluoroquinolones are contraindicated in pregnancy 1

HIV-infected patients:

  • Treat with the same regimens as HIV-negative patients 6

Critical Pitfalls to Avoid

  • Do not defer treatment if objective signs of urethritis are present and patient is unlikely to return for follow-up 4
  • Do not re-treat based on symptoms alone without documenting objective signs of urethritis 4
  • Always test for syphilis in patients with sexually transmitted urethritis, as high-dose short-course antibiotics may mask incubating syphilis 3
  • Ensure medication is provided directly in clinic when possible to improve compliance, especially for multi-dose regimens 4

References

Guideline

Urethritis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Urethral Discharge Without Pyuria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Mycoplasma genitalium and Ureaplasma Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and management of gonococcal infections.

American family physician, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.